Steve Martocci

And so what is interesting is like Pompe's, they're like, well, you don't have Pompe's disease, but you are a carrier.

But like, no one talks about subclinical Pompe's disease.

Like by having one copy of the gene, I have 30 to 70% less of the enzyme than a normal person would have.

I don't have full on floppy baby Pompe's, which is very terrible.

But like, wait a second, maybe this is the root of Pompe's.

why I've had so many struggles.

And I can't find like really like a doctor on the planet Earth who like talks about this stuff because they're treating disease.

But man, figuring this out with AI and blood work and like I was hoping I was going to get the results this morning for some lab work I'm doing, like really tracing down do I have how much of the enzyme and that kind of stuff.

But I'm like close.

We could only run the test through the Mayo Clinic and had to send it.

Like it's like, but there is some very cool, very positive, you know, consumer health that's going to come out of

the ai you know generation here both on um you know treatments and i think you know new therapeutics that are yeah well when you go to functional doctors or people that have stepped out to go do that kind of practice they take a lot of pride in figuring out figuring it out yeah right they want to figure it out yeah it's like that's that's cool yeah yeah

They don't have the time.

No.

And that's the whole thing I think that's so amazing about this AI era is, like, the cycles, the feedback loops were so long when it'd be like, schedule with the doctor, go talk to them about a condition, get blood work back.

It'd be like...

five months before you even have the one relevant conversation about how to do anything.

But now we have like, okay, asynchronously, go get your blood work over here.

Your function labs come back, put them into chat GPT, get an analysis, figure out already how to go.

Like it's just shrinking the path of care so well and empowering people so much.